News Release

Iowa City chemist wins national award for drug research

Grant and Award Announcement

American Chemical Society

Robert J. Linhardt of Iowa City, Iowa, will be honored March 25 by the world's largest scientific society for his achievements in understanding and improving pharmaceuticals based on carbohydrates, in particular the clot inhibitor heparin. He will receive the 2003 Claude S. Hudson Award in Carbohydrate Chemistry from the American Chemical Society at its national meeting in New Orleans.

"Carbohydrates have a lot of unique properties," said Linhardt, a professor of chemistry and chemical engineering at the University of Iowa. "In addition to being important to diet, they're also necessary whenever cells communicate with each other, for example. So they can make very powerful drugs, and heparin is one of them."

Researchers discovered heparin in 1916, learning the body produced it naturally to provide a slick lining for blood vessels. It's used today to keep blood flowing through artificial kidney and heart machines and to inhibit growth of blood clots in patients at risk for heart attack or stroke.

Heparin piqued Linhardt's interest 20 years ago as "an unsolved mystery of nature," he said. The drug is not one carbohydrate but a collection of millions, and researchers knew little about their specific structures, activities and roles in the body. He decided to study them and, by doing so, try to make a simpler, more selective version of the drug in the laboratory.

With his multidisciplinary team of carbohydrate chemists, biologists, medicinal chemists and pharmacologists, Linhardt eventually discovered one of what is now known as low-molecular-weight heparins. It is among the five such products currently prescribed by doctors.

"Low-molecular-weight heparins are a little more selective, but the real advantage is their cost efficiency," he said. Because they can be administered as daily shots rather than constantly dripped through a patient's IV solution, "they save hospital costs and keep a person functional."

Linhardt is now working on synthesizing a derivative structure of heparin, enabling pharmaceutical companies to manufacture the drug rather than harvest it from animal tissue.

Linhardt received his undergraduate degree from Marquette University in 1975 and his Ph.D. from Johns Hopkins University in 1979. He is a member of the ACS divisions of carbohydrate, organic and medicinal chemistry as well as the biotechnology division.

The Claude S. Hudson Award in Carbohydrate Chemistry is sponsored by National Starch and Chemical Co.

###


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.